Moteur de recherche d’entreprises européennes
Financement de l’UE (1 195 106 €) : Un tremplin vers la clinique de génétique du futur Hor01/01/2015 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Un tremplin vers la clinique de génétique du futur
The Genetics Clinic of the Future (GCOF) project aims to ensure that the clinical implementation of genome technologies is relevant and responsive to the needs of all. It offers a stepping stone approach towards the genetics clinic of the future, engaging all stakeholders involved in a process of mutual learning and information exchange. The GCOF project implements key Science with and for Society issues, ensuring that ethical reflection and stakeholder involvement do not occur in parallel, but are effectively integrated in the core of the project. It establishes a robust communication and implementation strategy that integrates the project’s outcomes and recommendations in research and clinical practices and policy processes, outlining opportunities for a more responsive health research and innovation system by: 1. Envisioning the Genetics Clinic of the Future (WP1) 2. Mapping out the concept of data control (WP2) 3. Considering ethical and legal dimensions in the consent framework (WP3) 4. Exploring novel models for use of clinical data in research and vice versa (WP4) 5. Initiating public engagement, mutual learning and dissemination (WP5) 6. Engaging policy makers (WP6) The consortium brings together 12 key partners from 10 countries across Europe who represent the breadth of stakeholders involved in the genetics clinic of the future: genomics research, clinical genetics, bioinformatics, public health, policy making, patient representation, education, commercial genetics and bioinformatics services, social research, communication, responsible innovation and ethics and law. The GCOF project connects to the major EU-initiatives in the field of personalised health and care. The consortium also represents a variety of organisation types, including research organisations, businesses, policy makers, civil society organisations, education establishments and science & society centres.
| Agilent Technologies Belgium N.V. | 65 000 € |
| BIO.Logis Genetic Information Management GmbH | 72 500 € |
| Eurordis - Rare Diseases Europe | 72 544 € |
| Institutet FOR Fremtidsforskning Forening | 70 000 € |
| Observa Associazione | 85 000 € |
| Open Science - Lebenswissenschaften IM Dialog | 92 188 € |
| Schuurbiers Daniel | 67 063 € |
| Terveyden JA Hyvinvoinnin Laitos | 105 313 € |
| The Chancellor, Masters and Scholars of the University of Oxford | 102 500 € |
| Universidade Nova de Lisboa | 127 500 € |
| Universitair Medisch Centrum Utrecht | 201 250 € |
| University of Leicester | 134 250 € |
https://cordis.europa.eu/project/id/643439
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.